FDA approves new drug treatments for type 2 diabetes

Authosr(s):

On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here